Showing results (91-100 of 258) with videos related to
Sort By:
Pageof 26
EMBO Reports|May 9, 2006
Tumour necrosis factor receptor 1 mediates endoplasmic reticulum stress-induced activation of the MAP kinase JNKQingfeng Yang, You-Sun Kim, Yong Lin, et al.Molecular Cancer Research : MCR|May 16, 2025
Mitochondrial HSP90 paralog TRAP1 deletion drives glutamine addiction in tumor cells via destablization of the Cys/Glu antiporter SLC7A11/xCTAbhinav Joshi, Li Dai, Marisa Maisiak, et al.Journal of Proteome Research|October 11, 2005
Direct identification of ubiquitination sites on ubiquitin-conjugated CHIP using MALDI mass spectrometryDongxia Wang, Wanping Xu, Sara C McGrath, et al.Proceedings of the National Academy of Sciences of the United States of America|July 18, 2006
Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activationFumitaka Koga, Wanping Xu, Tatiana S Karpova, et al.International Journal of Cancer|October 4, 2011
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cellsManabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, et al.Investigational New Drugs|June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumorsKhanh Do, Giovanna Speranza, Lun-Ching Chang, et al.Current Opinion in Oncology|October 9, 2008
Histone deacetylase inhibitors in cancer therapyMin-Jung Lee, Yeong Sang Kim, Shivaani Kummar, et al.Current Topics in Medicinal Chemistry|April 14, 2016
Targeting Hsp90 in Non-Cancerous MaladiesMark R Woodford, Diana M Dunn, Joseph G Ciciarelli, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2008
Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in boneAkihiro Yano, Shinji Tsutsumi, Shiro Soga, et al.Blood|April 9, 2004
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinibCem Akin, Gerard Fumo, Akif S Yavuz, et al.Pageof 26